Jaime Vieser serves as Executive at ZIOPHARM ONCOLOGY INC, where they oversee executive responsibilities. Since joining the company, Jaime Vieser has executed 6 insider transactions totaling $1.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 21, 2025 involved receiving (via award) 5,340 shares valued at $16.9K.
Jaime Vieser currently holds 26,499 shares of ZIOPHARM ONCOLOGY INC (ZIOP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jaime Vieser has been a net buyer of ZIOP stock. They have purchased $1.0M and sold $0 worth of shares.
Jaime Vieser's most recent insider trade was on Nov 21, 2025, when they sold 5,340 shares at $3.16 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 29, 2022 | TCRT | $812.5K | Purchase | 1,250,000 | $0.65 | Discretionary |
| Jun 22, 2022 | TCRT | $0 | Award | 40,000 | $N/A | Discretionary |
| Sep 29, 2021 | ZIOP | $191.0K | Purchase | 100,000 | $1.91 | Discretionary |
| Mar 4, 2021 | ZIOP | $0 | Award | 4,167 | $N/A | Discretionary |